Navigation Links
John Theurer Cancer Center among first clinical trial sites to join landmark MMRF study
Date:9/20/2011

September 20, 2011, Hackensack, N.J. The John Theurer Cancer Center at Hackensack University Medical Center, a top 50 U.S. News best hospital for cancer, is one of the first four clinical sites enrolling patients in a landmark study designed to uncover the molecular segments and variations of multiple myeloma. The study is the centerpiece of the Multiple Myeloma Research Foundation's (MMRF) Personalized Medicine Initiative, CoMMpass (Relating Clinical Outcomes in MM to Personal Assessment of Genetic Profile), aimed to accelerate translational research into therapeutic breakthroughs for patients.

"Over the past decade the multiple myeloma community has made significant progress developing therapies that extend survival and improve quality of life," said David S. Siegel, M.D., Ph.D., Chief, Multiple Myeloma, John Theurer Cancer Center and a Principal Investigator of the study, "This study is designed to build upon our most recent discovery the completion of the first genomic portrait of multiple myeloma. We hope to gain a greater understanding of the mechanisms of the disease to develop personalized treatments for our patients."

The study will enroll at least 1,000 newly diagnosed multiple myeloma patients who have not yet initiated therapy for their disease. Researchers will track patients from initial diagnosis through their course of treatment, over a minimum of 5 years, and conduct sequential tissue sampling to identify how a patient's molecular profile may affect his or her clinical progression and individual response to treatment.

"The John Theurer Cancer Center is committed to participating in clinical trials that may contribute to the development of more targeted treatments for patients," said Andrew L. Pecora, M.D., F.A.C.P., C.P.E., Chief Innovations Officer and Professor and Vice President of Cancer Services, John Theurer Cancer Center. "We are pleased to collaborate with the MMRF on this important research initiative." <
'/>"/>

Contact: Amy Leahing
amy.leahing@zibbel.com
305-458-0599
John Theurer Cancer Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Lymphoma Research Foundation and John Theurer Cancer Center collaborate for Lymphoma Rounds program
2. John Theurer Cancer Center and the Promise Foundation partner to offer free skin cancer screenings
3. The John Theurer Cancer Center to host Seventh Annual Neuro-Oncology Symposium
4. John Theurer Cancer Center first in New Jersey to offer complete capabilities of Provenge
5. The MMRF and John Theurer Cancer Center to host patient symposium
6. John Theurer Cancer Center orthopedic oncologist shares new limb sparing surgical techniques
7. John Theurer Cancer Center to host Eighth Annual Northern New Jersey Breast Cancer Conference
8. Oncology basic research director at John Theurer Cancer Center continues transplantation research
9. John Theurer Cancer Center presents studies on promising therapies for aggressive blood cancers
10. The John Theurer Cancer Center to unveil 40 presentations at the 52nd ASH Annual Meeting
11. John Theurer Cancer Center to present innovative research at 2 surgical meetings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... 2014 Zereana Jess-Huff, a 34-year-old mother, corporate ... on a platform to think outside the bra. She doesn’t ... position to raise awareness about women’s other lady parts. , ... You say the color pink and everybody knows what you’re ... fact that it has not been won when it comes ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 My Clients ... management software application. The new module enables easy ... receive full life-cycle quality care. , This application allows ... within their practice, attach a to-do item to a ... and even set up reoccurring reminders for follow-ups. ...
(Date:10/20/2014)... AttorneyOne.com, a recognized authority on law, update the ... on Sit and Slim II . , The ... use Sit and Slim II because it contains Sibutramine ... weight loss product on various websites and possibly in some ... for safety reasons, can significantly increase blood pressure and/or pulse ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 Rockynol ... Living Center on Oct. 14. The $11 million project ... services, and a cooked-to-order kitchen with full-service restaurant style ... premier choice for first class Assisted Living apartments,” said ... residents deserve the highest quality of care and this ...
(Date:10/20/2014)... Based on a proprietary chromatid-specific ... assays capable of determining DNA sequence, location and ... three dimensions of high-resolution data, dGH assays are ... range of disease-causing genetic rearrangements, including chromosomal inversions ... tools, including today’s advanced sequencing technologies. , According ...
Breaking Medicine News(10 mins):Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 2Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 3Health News:My Clients Plus Announces New Workflow Management Software 2Health News:FDA Advises Not to Use Sit and Slim II: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Rockynol Retirement Community Expands Assisted Living Center 2Health News:KromaTiD Launches Genome Screening and Discovery Services 2Health News:KromaTiD Launches Genome Screening and Discovery Services 3
... his arms in an accident is getting some high-tech help ... ,Two years ago, a healthy Jesse Sullivan, 56, ... touched a live wire,// costing him both his arms up ... with a traditional artificial prosthesis, relying on chains and buttons ...
... of using a bell and meat powder, which is what ... intrinsic significance and coupled those to food smells," said Dr. ... ,Gottfried was trying to explain what he calls the "restaurant ... your birthday and you have gone though all the appetizers ...
... but gold can. In a remarkable experiment, Indian scientists have developed ... as the 'factory'. ,But before rushing to try cultivating fig trees ... caution : The scientists have been able to use the micro- ... human hair.// ,And therein lies the beauty of the new gold. ...
... Polycystic Ovarian Syndrome(PCOS),a condition which affects women of child-bearing ... testosterone, the so-called male hormone, rendering them unable to ... of facial hair, though scientists have said women// without ... also are a PCOS trait, though women's health experts ...
... one of the most exquisite pieces of engineering in the ... vulnerable to a debilitating degeneration as a result of the ... to blindness. These parts have to be kept from wearing ... lifetime. This, researchers have found, is possible through nutrients that ...
... accompanied by visual disturbances as well as sensitivity ... respond to a drug hitherto used to treat ... that drugs like candesartan cilexetil (Atacand) reduces the ... team decided to study Atacand after a colleague ...
Cached Medicine News:Health News:A man who lost both of his arms in an accident 2Health News:Brain scans show why we always have room for dessert 2Health News:Cultivating gold on a fig tree 2Health News:Polycystic Ovarian Syndrome(PCOS) linked to Diabetes 2Health News:Drug used to treat hypertension effective in countering Migraines 2
(Date:10/18/2014)... 2014  In a policy paper ... nation,s largest lesbian, gay, bisexual and transgender (LGBT) ... Truvada for Pre-Exposure Prophylaxis (PrEP). PrEP is any ... the spread of a disease or infection prior ... anti-HIV drug combination currently approved for PrEP, which ...
(Date:10/17/2014)... AUSTIN, Texas , Oct. 17, 2014  Hanger, ... it plans to report its results of operations for ... 6, 2014 after the market closes.  A conference call ... 9:00 a.m., ET, on Friday, November 7, 2014. Those ... be available until Friday, November 14, 2014 by dialing ...
(Date:10/17/2014)... Research ... addition of the  "China Interventional Cardiovascular Device ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) The ... China impacted by accelerated aging ... dietary habit, way of working and other ...
Breaking Medicine Technology:HRC Endorses PrEP, Calls for Bold Action to Expand Access to Anti-HIV Drug 2HRC Endorses PrEP, Calls for Bold Action to Expand Access to Anti-HIV Drug 3China Interventional Cardiovascular Device Industry Report 2014-2017 2China Interventional Cardiovascular Device Industry Report 2014-2017 3
... DIEGO , May 6 Orexigen® Therapeutics, Inc. (Nasdaq: OREX ... financial results for the first quarter ended March 31, 2010 on ... followed by a live webcast and conference call at 5:00 p.m. Eastern ... Orexigen management will ...
... , May 6 DUSA Pharmaceuticals, Inc. ( DUSA ) announces that its corporate ... 6:30 a.m. to be followed by a conference call at 8:30 a.m. , ... - 8:30 a.m. E.T. , , , ... , , 800-647-4314 , ...
Cached Medicine Technology:Orexigen(R) Therapeutics Schedules May 10, 2010 Webcast Discussion of Financial Results for the First Quarter Ended March 31, 2010 2DUSA Pharmaceuticals, Inc.(R) to Host First Quarter 2010 Corporate Highlights and Financial Results Conference Call 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: